CTI BioPharma Corp. (CTIC) released Loss for its fourth quarter that increased from the same period last year
The company's earnings totaled -$36.79 million, or -$0.38 per share. This compares with -$15.00 million, or -$0.20 per share, in last year's fourth quarter.
CTI BioPharma Corp. earnings at a glance (GAAP) :
-Earnings (Q4): -$36.79 Mln. vs. -$15.00 Mln. last year.
-EPS (Q4): -$0.38 vs. -$0.20 last year.
For comments and feedback contact: editorial@rttnews.com